Pharmacotherapy for patients with fibromyalgia
Pharmacotherapy for patients with fibromyalgia
复制标题
DOI：
10.4088/jcp.1108e33
复制
发表时间：
2008-01-01
影响因子：
5.3
通讯作者：
Clauw, Daniel J.
中科院分区：
文献类型：
--
作者：
Clauw, Daniel J.
Fibromyalgia is a common and disabling syndrome. Despite research detailing the efficacy of a variety of medicinal treatments, most notably, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and alpha(2)delta ligands, there is still widespread, routine use of agents that are mostly ineffective in treating the central nature of fibromyalgic pain. This article discusses pharmacotherapeutic options for fibromyalgia, including those with high-level evidence for efficacy, moderate-level evidence, and little or no evidence for efficacy. The importance of an integrated treatment approach that includes pharmacotherapy and at least one, but preferably more, of the most effective nonmedicinal treatment options available (e.g., education, aerobic exercise, and cognitive-behavioral therapy) is also discussed.
